Stock & Company Details
Fortrea Holdings Inc $FTRE
Price:
N/A
N/A
95M
$2.5B
52 Week High:
N/A
10 Day Average Volume:
N/A
-25.41
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
FTRE technical indicators
Latest Fortrea Holdings Inc (FTRE) indicator readings as of 2026-10-29.
FTRE's 14-day RSI is 56.2, in neutral territory. At $23.14 it is trading 47.6% above its 200-day moving average of $15.67, and above its 50-day average of $20.22. Price sits in the middle of its Bollinger Bands ($19.13 to $25.50). ADX reads 43.8, indicating a trending market.
Overview
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Finance Bot
Ask your questions
Start by typing a question below.
